Winslow Capital Management
EXAS

Winslow Capital Management’s Exact Sciences EXAS Stock Holding History

Winslow Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,460,349
Closed -$228M – 59
2019
Q4 		$228M Sell
2,460,349
-119,545
-5% -$10.5M 1.18% 34
2019
Q3 		$233M Buy
2,579,894
+330,129
+15% +$37.6M 1.27% 34
2019
Q2 		$266M Sell
2,249,765
-75,176
-3% -$7.57M 1.42% 32
2019
Q1 		$201M Buy
+2,324,941
New +$198M 1.09% 43

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Winslow Capital Management's EXAS Position: Q1 2020 in Review

Winslow Capital Management sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 2,460,349 shares — an estimated $228M sold.

Winslow Capital Management first reported a position in EXAS in Q1 2019 and held it in 4 quarters. The position peaked at $266M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

  • Winslow Capital Management reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
  • Winslow Capital Management sold 2,460,349 Exact Sciences shares in Q1 2020, an estimated $228M.
  • Winslow Capital Management first reported a position in Exact Sciences in Q1 2019 and held it in 4 quarters.
  • Winslow Capital Management's Exact Sciences position peaked at $266M in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Winslow Capital Management's 13F filing for Q1 2020, filed 15 May 2020.